Cutanea files for IPO

Cutanea Life Sciences Inc. (Malvern, Pa.) filed to raise up to $15 million in an IPO underwritten by Brean Murray and Rodman. Cutanea's lead compound, omiganan ( CLS001), is expected to start Phase II...